Analysis shows lymphocyte-monocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma, suggesting a potential biomarker for treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Chengli Jiang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: